文献速递血液净化与透析

血液透析患者动静脉内瘘照护连续体中的种族差异

Racial Disparities in the Arteriovenous Fistula Care Continuum in Hemodialysis Patients.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-10-20

该研究基于美国肾脏数据系统医保索赔数据,对2010年7月至2012年6月间以中心静脉导管起始血液透析的≥67岁患者进行纵向分析,比较黑人与白人在动静脉内瘘创建、成功使用及初级通畅性三个连续步骤上的差异。调整竞争风险后,黑人患者在内瘘放置、成功使用及维持初级通畅性方面均显著低于白人。

要点

  • 黑人透析患者内瘘放置可能性比白人低10%(aHR 0.90)。
  • 内瘘放置后成功使用可能性低12%(aHR 0.88)。
  • 成功使用后维持初级通畅性可能性低22%(aHR 0.78)。

核心结论

  • 黑人老年血液透析患者内瘘使用率较低可归因于内瘘照护连续体中的每一个步骤。

研究设计与样本

  • 基于美国肾脏数据系统医保索赔数据的纵向分析,纳入≥67岁、2010年7月1日至2012年6月30日以中心静脉导管起始血液透析的患者。
  • 三个队列:以导管起始透析者(n=41,814)、透析起始6个月内放置内瘘者(n=14,077)、内瘘放置后6个月内成功使用者(n=7,068)。

主要发现

  • 以导管起始透析的患者中,37%在6个月内放置内瘘。
  • 放置内瘘的患者中,48%在6个月内成功用于透析。
  • 成功使用内瘘的患者中,21%在3年时维持初级通畅。
  • 调整竞争风险后,黑人患者内瘘放置可能性低10%(aHR 0.90,95%CI 0.87-0.94)。
  • 黑人患者内瘘成功使用可能性低12%(aHR 0.88,95%CI 0.83-0.93),维持初级通畅可能性低22%(aHR 0.78,95%CI 0.74-0.84)。

临床怎么用

  • 针对内瘘照护连续体的每个环节(放置、成功使用、维持通畅)筛查并干预种族差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Arteriovenous fistulas are the optimal vascular access type for patients on hemodialysis. However, arteriovenous fistulas are used less frequently in Black than in White individuals. The arteriovenous fistula care continuum comprises a series of sequential steps. A better understanding is needed of where disparities exist along the continuum in order to mitigate racial differences in arteriovenous fistula use. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using Medicare claims data from the United States Renal Data System, longitudinal analyses of patients ≥67 years initiating hemodialysis with a central venous catheter between July 1, 2010 and June 30, 2012 were performed. Three patient cohorts were identified: patients initiating hemodialysis with a catheter (n=41,814), patients with arteriovenous fistula placement within 6 months of dialysis initiation (n=14,077), and patients whose arteriovenous fistulas were successfully used within 6 months of placement (n=7068). Three arteriovenous fistula processes of care outcomes were compared between Blacks and Whites: (1) arteriovenous fistula creation, (2) successful arteriovenous fistula use, and (3) primary arteriovenous fistula patency after successful use. RESULTS: An arteriovenous fistula was placed within 6 months of dialysis initiation in 37% of patients initiating dialysis with a catheter. Among the patients with arteriovenous fistula placement, the arteriovenous fistula was successfully used for dialysis within 6 months in 48% of patients. Among patients with successful arteriovenous fistula use, 21% maintained primary arteriovenous fistula patency at 3 years. After adjusting for competing risks, Black patients on hemodialysis were 10% less likely to undergo arteriovenous fistula placement (adjusted subdistribution hazard ratio, 0.90; 95% confidence interval, 0.87 to 0.94); 12% less likely to have successful arteriovenous fistula use after placement (adjusted subdistribution hazard ratio, 0.88; 95% confidence interval, 0.83 to 0.93); and 22% less likely to maintain primary arteriovenous fistula patency after successful use (subdistribution hazard ratio, 0.78; 95% confidence interval, 0.74 to 0.84). CONCLUSIONS: Lower arteriovenous fistula use among Blacks older than 67 years of age treated with hemodialysis was attributable to each step along the continuum of arteriovenous fistula processes of care.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Qian J, Lee T, Thamer M, et al. Racial Disparities in the Arteriovenous Fistula Care Continuum in Hemodialysis Patients. Clin J Am Soc Nephrol. 2020. PMID: 33082199. doi:10.2215/CJN.03600320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。